These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35293602)

  • 21. Impact of Galectins in Resistance to Anticancer Therapies.
    Navarro P; Martínez-Bosch N; Blidner AG; Rabinovich GA
    Clin Cancer Res; 2020 Dec; 26(23):6086-6101. PubMed ID: 32709716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of galectin-3 in the pathogenesis of bladder transitional cell carcinoma.
    Zeinali M; Adelinik A; Papian S; Khorramdelazad H; Abedinzadeh M
    Hum Immunol; 2015 Oct; 76(10):770-4. PubMed ID: 26429330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New biological treatments for gynecological tumors: focus on angiogenesis.
    Daniele G; Di Maio M; Piccirillo MC; Giordano P; Capuano I; Cecere SC; Bryce JC; Pignata S; Perrone F
    Expert Opin Biol Ther; 2014 Mar; 14(3):337-46. PubMed ID: 24387684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular galectins in cancer cells: potential new targets for therapy (Review).
    Vladoiu MC; Labrie M; St-Pierre Y
    Int J Oncol; 2014 Apr; 44(4):1001-14. PubMed ID: 24452506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of reproductive hormones in epithelial ovarian carcinogenesis.
    Gharwan H; Bunch KP; Annunziata CM
    Endocr Relat Cancer; 2015 Dec; 22(6):R339-63. PubMed ID: 26373571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Galectins in Multiple Myeloma.
    Storti P; Marchica V; Giuliani N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer.
    Wellman TL; Eckenstein M; Wong C; Rincon M; Ashikaga T; Mount SL; Francklyn CS; Lounsbury KM
    BMC Cancer; 2014 Aug; 14():620. PubMed ID: 25163878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of Galectin-7 in Cancer.
    Kaur M; Kaur T; Kamboj SS; Singh J
    Asian Pac J Cancer Prev; 2016; 17(2):455-61. PubMed ID: 26925627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis and molecular markers in advanced epithelial ovarian cancer: a retrospective study.
    Ferrero A; Dompè D; Ravarino N; Ramella A; Fuso L; Maggiorotto F; Tripodi E; Zola P
    Gynecol Oncol; 2011 Nov; 123(2):301-7. PubMed ID: 21862119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular galectins: regulators of tumor progression and targets for cancer therapy.
    Thijssen VL; Rabinovich GA; Griffioen AW
    Cytokine Growth Factor Rev; 2013 Dec; 24(6):547-58. PubMed ID: 23942184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galectin-8: a matricellular lectin with key roles in angiogenesis.
    Troncoso MF; Ferragut F; Bacigalupo ML; Cárdenas Delgado VM; Nugnes LG; Gentilini L; Laderach D; Wolfenstein-Todel C; Compagno D; Rabinovich GA; Elola MT
    Glycobiology; 2014 Oct; 24(10):907-14. PubMed ID: 24939370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic and prognostic value of tumor markers, scores (clinical and biological) algorithms, in front of an ovarian mass suspected of an epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Bendifallah S; Body G; Daraï E; Ouldamer L
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):134-154. PubMed ID: 30733191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers.
    Labrie M; De Araujo LOF; Communal L; Mes-Masson AM; St-Pierre Y
    Sci Rep; 2017 Oct; 7(1):13244. PubMed ID: 29038585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galectins in the Tumor Microenvironment: Focus on Galectin-1.
    Martínez-Bosch N; Navarro P
    Adv Exp Med Biol; 2020; 1259():17-38. PubMed ID: 32578169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma.
    Videla-Richardson GA; Morris-Hanon O; Torres NI; Esquivel MI; Vera MB; Ripari LB; Croci DO; Sevlever GE; Rabinovich GA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression Levels of Follicle-Stimulating Hormone Receptor and Implication in Diagnostic and Therapeutic Strategy of Ovarian Cancer.
    Wei S; Lai L; Yang J; Zhuandi G
    Oncol Res Treat; 2018; 41(10):651-654. PubMed ID: 30145593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCL11 mediates TWIST1-induced angiogenesis in epithelial ovarian cancer.
    Koo YJ; Kim TJ; Min KJ; So KA; Jung US; Hong JH
    Tumour Biol; 2017 May; 39(5):1010428317706226. PubMed ID: 28488542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance.
    Krishna Priya S; Kumar K; Hiran KR; Bindhu MR; Nagare RP; Vijaykumar DK; Ganesan TS
    Int J Clin Oncol; 2017 Feb; 22(1):107-117. PubMed ID: 27567920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.
    Lahm H; André S; Hoeflich A; Fischer JR; Sordat B; Kaltner H; Wolf E; Gabius HJ
    J Cancer Res Clin Oncol; 2001; 127(6):375-86. PubMed ID: 11414198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.